|

Chimeric Antigen Receptor Clinical Trials

1 actively recruiting trial

Also known as: Chimeric antigen receptor modified T cells

Top Sponsors

  • Ruijin Hospital1

Indications

  • Lymphoma, Non-Hodgkin1
  • Cancer1

Other1 trial

Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.